ABMD logo

Abiomed (ABMD) Cash From Operations

Annual CFO

$285.39 M
+$10.81 M+3.94%

31 March 2022

ABMD Cash From Operations Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly CFO

$13.42 M
-$54.68 M-80.29%

30 September 2022

ABMD Quarterly CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM CFO

$250.98 M
-$47.15 M-15.82%

30 September 2022

ABMD TTM CFO Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ABMD Cash From Operations Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+3.9%-85.2%-14.3%
5 y5 years+13.2%-85.0%-16.0%

ABMD Cash From Operations High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-9.4%-85.2%-20.3%

Abiomed Cash From Operations History

DateAnnualQuarterlyTTM
Sept 2022
-
$13.42 M(-80.3%)
$250.98 M(-15.8%)
June 2022
-
$68.10 M(-13.8%)
$298.13 M(+4.5%)
Mar 2022
$285.39 M(+3.9%)
$78.97 M(-12.7%)
$285.39 M(-2.6%)
Dec 2021
-
$90.49 M(+49.4%)
$292.89 M(+4.0%)
Sept 2021
-
$60.57 M(+9.4%)
$281.54 M(-5.6%)
June 2021
-
$55.36 M(-36.0%)
$298.18 M(+8.6%)
Mar 2021
$274.58 M(-12.8%)
$86.47 M(+9.3%)
$274.58 M(-0.0%)
Dec 2020
-
$79.14 M(+2.5%)
$274.70 M(-3.6%)
Sept 2020
-
$77.21 M(+143.1%)
$285.00 M(+1.0%)
June 2020
-
$31.76 M(-63.3%)
$282.05 M(-10.4%)
Mar 2020
$314.92 M(+24.9%)
$86.59 M(-3.2%)
$314.92 M(+5.4%)
Dec 2019
-
$89.44 M(+20.4%)
$298.72 M(+5.2%)
Sept 2019
-
$74.26 M(+14.9%)
$283.89 M(+5.1%)
June 2019
-
$64.63 M(-8.2%)
$270.19 M(+7.1%)
Mar 2019
$252.20 M(+31.0%)
$70.39 M(-5.7%)
$252.20 M(+5.9%)
Dec 2018
-
$74.61 M(+23.2%)
$238.21 M(+8.1%)
Sept 2018
-
$60.56 M(+29.9%)
$220.29 M(+8.6%)
June 2018
-
$46.63 M(-17.3%)
$202.88 M(+5.4%)
Mar 2018
$192.55 M(+67.3%)
$56.40 M(-0.5%)
$192.55 M(+11.0%)
Dec 2017
-
$56.70 M(+31.4%)
$173.40 M(+15.0%)
Sept 2017
-
$43.16 M(+18.9%)
$150.83 M(+20.6%)
June 2017
-
$36.29 M(-2.6%)
$125.03 M(+8.6%)
Mar 2017
$115.12 M(+49.9%)
$37.26 M(+9.2%)
$115.12 M(+14.6%)
Dec 2016
-
$34.13 M(+96.6%)
$100.42 M(+9.5%)
Sept 2016
-
$17.36 M(-34.2%)
$91.67 M(-0.6%)
June 2016
-
$26.38 M(+16.9%)
$92.26 M(+20.1%)
Mar 2016
$76.80 M(+77.4%)
$22.56 M(-11.1%)
$76.80 M(+5.9%)
Dec 2015
-
$25.38 M(+41.5%)
$72.50 M(+16.5%)
Sept 2015
-
$17.94 M(+64.4%)
$62.24 M(+22.0%)
June 2015
-
$10.91 M(-40.2%)
$51.01 M(+17.8%)
Mar 2015
$43.29 M(+84.5%)
$18.26 M(+20.7%)
$43.29 M(+24.0%)
Dec 2014
-
$15.13 M(+125.3%)
$34.92 M(+23.6%)
Sept 2014
-
$6.71 M(+110.4%)
$28.25 M(+5.8%)
June 2014
-
$3.19 M(-67.8%)
$26.69 M(+13.7%)
Mar 2014
$23.47 M(-11.1%)
$9.89 M(+17.1%)
$23.47 M(+11.1%)
Dec 2013
-
$8.45 M(+63.9%)
$21.13 M(+3.6%)
Sept 2013
-
$5.16 M(<-9900.0%)
$20.39 M(-7.5%)
June 2013
-
-$33.00 K(-100.4%)
$22.05 M(-16.5%)
Mar 2013
$26.40 M(+626.4%)
$7.56 M(-2.0%)
$26.40 M(+10.8%)
Dec 2012
-
$7.71 M(+13.1%)
$23.83 M(+13.2%)
Sept 2012
-
$6.81 M(+57.8%)
$21.06 M(+27.6%)
June 2012
-
$4.32 M(-13.5%)
$16.51 M(+354.3%)
Mar 2012
$3.63 M(+130.9%)
$4.99 M(+1.3%)
$3.63 M(-399.6%)
Dec 2011
-
$4.93 M(+117.6%)
-$1.21 M(+331.7%)
Sept 2011
-
$2.27 M(-126.5%)
-$281.00 K(-93.5%)
June 2011
-
-$8.56 M(-5960.3%)
-$4.33 M(-375.4%)
Mar 2011
$1.57 M(-121.4%)
$146.00 K(-97.5%)
$1.57 M(+13.5%)
Dec 2010
-
$5.86 M(-427.9%)
$1.39 M(-130.1%)
Sept 2010
-
-$1.79 M(-32.5%)
-$4.60 M(-13.9%)
June 2010
-
-$2.65 M(+6356.1%)
-$5.35 M(-27.4%)
Mar 2010
-$7.36 M(-59.8%)
-$41.00 K(-67.5%)
-$7.36 M(-4.9%)
Dec 2009
-
-$126.00 K(-95.0%)
-$7.74 M(-23.7%)
Sept 2009
-
-$2.53 M(-45.7%)
-$10.14 M(-8.3%)
June 2009
-
-$4.66 M(+1004.7%)
-$11.06 M(-39.6%)
Mar 2009
-$18.30 M(-36.6%)
-$422.00 K(-83.3%)
-$18.30 M(-28.0%)
Dec 2008
-
-$2.53 M(-26.7%)
-$25.44 M(-11.9%)
Sept 2008
-
-$3.45 M(-71.0%)
-$28.89 M(+3.2%)
June 2008
-
-$11.90 M(+57.6%)
-$27.99 M(-3.1%)
Mar 2008
-$28.87 M(+45.7%)
-$7.56 M(+26.4%)
-$28.87 M(+3.8%)
Dec 2007
-
-$5.98 M(+134.5%)
-$27.83 M(+4.4%)
Sept 2007
-
-$2.55 M(-80.1%)
-$26.65 M(-3.7%)
June 2007
-
-$12.79 M(+96.5%)
-$27.67 M(+39.6%)
Mar 2007
-$19.82 M
-$6.51 M(+35.5%)
-$19.82 M(+45.9%)
DateAnnualQuarterlyTTM
Dec 2006
-
-$4.80 M(+34.5%)
-$13.59 M(+16.0%)
Sept 2006
-
-$3.57 M(-27.7%)
-$11.71 M(+6.9%)
June 2006
-
-$4.94 M(+1689.5%)
-$10.96 M(+17.4%)
Mar 2006
-$9.34 M(+80.8%)
-$276.00 K(-90.6%)
-$9.34 M(-8.7%)
Dec 2005
-
-$2.93 M(+4.0%)
-$10.23 M(+47.5%)
Sept 2005
-
-$2.82 M(-15.0%)
-$6.94 M(+20.9%)
June 2005
-
-$3.31 M(+183.3%)
-$5.74 M(+11.1%)
Mar 2005
-$5.16 M(-49.1%)
-$1.17 M(-419.7%)
-$5.16 M(-23.8%)
Dec 2004
-
$366.00 K(-122.6%)
-$6.78 M(-22.4%)
Sept 2004
-
-$1.62 M(-40.9%)
-$8.73 M(-3.7%)
June 2004
-
-$2.74 M(-1.5%)
-$9.07 M(-10.6%)
Mar 2004
-$10.14 M(-37.4%)
-$2.78 M(+75.5%)
-$10.14 M(-6.7%)
Dec 2003
-
-$1.59 M(-18.9%)
-$10.87 M(-8.5%)
Sept 2003
-
-$1.96 M(-48.7%)
-$11.88 M(-9.7%)
June 2003
-
-$3.81 M(+8.4%)
-$13.15 M(-18.7%)
Mar 2003
-$16.18 M(-17.5%)
-$3.52 M(+35.2%)
-$16.18 M(-15.2%)
Dec 2002
-
-$2.60 M(-19.4%)
-$19.10 M(-10.8%)
Sept 2002
-
-$3.23 M(-52.8%)
-$21.40 M(-5.9%)
June 2002
-
-$6.84 M(+6.5%)
-$22.73 M(+15.9%)
Mar 2002
-$19.61 M(+69.6%)
-$6.43 M(+31.1%)
-$19.61 M(+16.6%)
Dec 2001
-
-$4.90 M(+7.5%)
-$16.83 M(+17.6%)
Sept 2001
-
-$4.56 M(+22.7%)
-$14.31 M(+14.6%)
June 2001
-
-$3.72 M(+2.1%)
-$12.48 M(+7.9%)
Mar 2001
-$11.57 M(+58.3%)
-$3.64 M(+52.4%)
-$11.57 M(+17.6%)
Dec 2000
-
-$2.39 M(-12.7%)
-$9.83 M(+4.1%)
Sept 2000
-
-$2.74 M(-2.3%)
-$9.44 M(+20.5%)
June 2000
-
-$2.80 M(+46.9%)
-$7.83 M(+7.2%)
Mar 2000
-$7.31 M(-1.3%)
-$1.91 M(-4.7%)
-$7.31 M(+0.4%)
Dec 1999
-
-$2.00 M(+77.4%)
-$7.28 M(+2.4%)
Sept 1999
-
-$1.13 M(-50.4%)
-$7.10 M(-6.1%)
June 1999
-
-$2.27 M(+21.0%)
-$7.56 M(+2.2%)
Mar 1999
-$7.40 M(+957.1%)
-$1.88 M(+2.9%)
-$7.40 M(+3.9%)
Dec 1998
-
-$1.83 M(+15.1%)
-$7.12 M(+62.0%)
Sept 1998
-
-$1.59 M(-24.8%)
-$4.40 M(+56.5%)
June 1998
-
-$2.11 M(+31.8%)
-$2.81 M(+301.3%)
Mar 1998
-$700.00 K(+250.0%)
-$1.60 M(-277.8%)
-$700.00 K(-154.7%)
Dec 1997
-
$900.00 K(>+9900.0%)
$1.28 M(-510.6%)
Sept 1997
-
$0.00(0.0%)
-$311.90 K(-22.0%)
June 1997
-
$0.00(-100.0%)
-$400.10 K(+100.0%)
Mar 1997
-$200.00 K(-135.3%)
$380.60 K(-155.0%)
-$200.10 K(-72.4%)
Dec 1996
-
-$692.50 K(+685.1%)
-$724.10 K(-254.3%)
Sept 1996
-
-$88.20 K(-144.1%)
$469.40 K(-11.0%)
June 1996
-
$200.00 K(-239.5%)
$527.20 K(-7.0%)
Mar 1996
$566.90 K(-37.0%)
-$143.40 K(-128.6%)
$567.00 K(-68.7%)
Dec 1995
-
$501.00 K(-1748.0%)
$1.81 M(+12.5%)
Sept 1995
-
-$30.40 K(-112.7%)
$1.61 M(-34.0%)
June 1995
-
$239.80 K(-78.2%)
$2.44 M(+171.1%)
Mar 1995
$900.00 K(-126.5%)
$1.10 M(+266.7%)
$900.00 K(-190.0%)
Dec 1994
-
$300.00 K(-62.5%)
-$1.00 M(-37.5%)
Sept 1994
-
$800.00 K(-161.5%)
-$1.60 M(-54.3%)
June 1994
-
-$1.30 M(+62.5%)
-$3.50 M(+2.9%)
Mar 1994
-$3.40 M(-20.9%)
-$800.00 K(+166.7%)
-$3.40 M(+3.0%)
Dec 1993
-
-$300.00 K(-72.7%)
-$3.30 M(-21.4%)
Sept 1993
-
-$1.10 M(-8.3%)
-$4.20 M(0.0%)
June 1993
-
-$1.20 M(+71.4%)
-$4.20 M(-2.3%)
Mar 1993
-$4.30 M(+26.5%)
-$700.00 K(-41.7%)
-$4.30 M(0.0%)
Dec 1992
-
-$1.20 M(+9.1%)
-$4.30 M(+4.9%)
Sept 1992
-
-$1.10 M(-15.4%)
-$4.10 M(+20.6%)
June 1992
-
-$1.30 M(+85.7%)
-$3.40 M(0.0%)
Mar 1992
-$3.40 M(-15.0%)
-$700.00 K(-30.0%)
-$3.40 M(+25.9%)
Dec 1991
-
-$1.00 M(+150.0%)
-$2.70 M(+58.8%)
Sept 1991
-
-$400.00 K(-69.2%)
-$1.70 M(+30.8%)
June 1991
-
-$1.30 M
-$1.30 M
Mar 1991
-$4.00 M
-
-

FAQ

  • What is Abiomed annual cash flow from operations?
  • What is the all time high annual CFO for Abiomed?
  • What is Abiomed quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Abiomed?
  • What is Abiomed TTM cash flow from operations?
  • What is the all time high TTM CFO for Abiomed?

What is Abiomed annual cash flow from operations?

The current annual CFO of ABMD is $285.39 M

What is the all time high annual CFO for Abiomed?

Abiomed all-time high annual cash flow from operations is $314.92 M

What is Abiomed quarterly cash flow from operations?

The current quarterly CFO of ABMD is $13.42 M

What is the all time high quarterly CFO for Abiomed?

Abiomed all-time high quarterly cash flow from operations is $90.49 M

What is Abiomed TTM cash flow from operations?

The current TTM CFO of ABMD is $250.98 M

What is the all time high TTM CFO for Abiomed?

Abiomed all-time high TTM cash flow from operations is $314.92 M